A rare complex mutation in FMF gene; genetics and treatment decisions in Familial Mediterranean Fever patients
Journal Title: International Journal of Clinical Rheumatology - Year 2018, Vol 13, Issue 3
Abstract
Introduction: FMF is an autosomal-recessive autoinflammatory disease characterized by episodic, self-limiting attacks characterized by fever, abdominal pain, pleurisy, arthritis and erysipelas-like-erythema. Systemic amyloidosis is the most severe manifestation of the disease. Case: 3 year old patient for evaluation of FMF who was referred because of gastrointestinal symptoms and a paternal family history of FMF. He had a number of gastrointestinal symptoms as an infant up to the age of 8 months, since the age of 1 year the patient had had 2 episodes each lasting 2 months, during which he would be sick every week with fever and severe abdominal pain and vomiting. The patient met the criteria for FMF based on the criteria from the Sheba medical center of Tel Hashomer in Israel. The patient was determined to have rare heterozygous complex mutation with E148Q-P369S-R408Q in cis state. Testing of his parents revealed that he had inherited all of the mutations from his mother despite the paternal familial history of FMF. Since amyloidosis is rare in Ashkenazi families and due to absence of mutations liked with high risk of amyloidosis, it was determined that he did not need chronic colchicine therapy. To best of our knowledge this is the third reported case of FMF with this gene complex and the first reported case in a patient of Shephardic and Ashkenazi Jewish ancestry. Conclusion: E148Q, P369S and R408Q when present separately are associated with a mild phenotype and incomplete penetrance, but when present together in cis form on same allele may lead to increased penetrance and clinical disease.
Influence of single nucleotide polymorphisms on the efficacy of platelet-rich plasma in the treatment of injuries
Tissue repair in musculoskeletal injuries is often a slow and sometimes incomplete process. Musculoskeletal injuries have a great impact on athletes’ especially elite athletes – and a rapid recovery of full efficiency an...
Recurrent life-threatening bleeding due to acquired clotting factor XIII inhibitor in a Chinese patient with systemic lupus erythematosus
A 52-year-old Chinese male with systemic lupus erythematosus presented with recurrent retroperitoneal haematoma and finally died of aggressive bleeding complications related to acquired clotting factor XIII inhibitor. We...
Application of treat-to-target principles in patients with early rheumatoid arthritis in routine clinical practice in Central-Eastern Europe
Objective: Understanding the extent to which treat-to-target (T2T) recommendations are applied by rheumatologists in patients with rheumatoid arthritis (RA) may identify gaps or issues in disease management. This study e...
“Cellular matrix™ PRP-HA”: A new treatment option with platelet-rich plasma and hyaluronic acid for patients with osteoarthritis having had an unsatisfactory clinical response to hyaluronic acid alone: Results of a pilot, multicenter French study with long-term follow-up
Objective: To evaluate the safety and efficacy of Cellular Matrix™, a new medical device designed for one-step preparation of platelet-rich plasma in presence of hyaluronic acid, for the management of tibiofemoral knee o...
Body image in lupus: Is it disease activity, physical function, depression, pain, fatigue, sleep, fibromyalgia or stress?
Patients with systemic lupus erythematosus (SLE) frequently experience poor body image (BI), an important issue, though not well researched or understood thus far. BI is perception of one’s own body. The effects of disea...